Analysis and characterization of a novel metallophosphoesterase from Akkermansia muciniphila involved in lipid degradation
Abstract
Gut microbes play an important role in the regulation of host health. Multiple studies have shown that Akkermansia muciniphila , as a promising beneficial gut bacterium, is robustly associated with positive effects on host metabolism, immunological regulation, and its presence inversely correlates with body weight. But the precise function played by this bacterium underlying lipid degradation is still unknown. Here we identify a metallophosphoesterase from A. muciniphila. The metallophosphoesterase is composed of a binuclear metal center connected with tyrosine residues and a highly conserved calcineurin-like_PHP_ApaH domain. The enzyme activity has reached its peak in the conditions of pH 8.0, temperature of 37 °C. The enzyme is active for esters with short fatty-acid chains, and has high catalytic activity for hydrolysis of phospholipid sodium salts. In addition, five of predicted active sites of the metallophosphoesterase affecting its enzymatic activity are individually analyzed. Point mutation of H47 reduces the catalytic activity of the metallophosphoesterase for its most preferred substrate, while mutation of H181 has the opposite effect of increasing the enzymatic activity. Overall, we report the first characterization of AMUC-1901, a novel metallophosphoesterase from A. muciniphila with lipid degradation capabilities, which has potential for further exploration in developing novel food or pharma supplements for obesity therapies. • Akkermansia muciniphila is a beneficial gut bacterium to play important role for human health. • A novel metallophosphoesterase from A. muciniphila can hydrolyze esters and phospholipids at suitable PH and temperature. • The metallophosphoesterase can be developed as a promising food or pharma candidate for lipid degradation.
Fields of Study & Subjects
Sphingolipid Metabolism and Signaling
Carbohydrate Chemistry and Synthesis
Signaling Pathways in Disease
Publication details
- Journal / source
- Biochemistry and Biophysics Reports
- Volume
- 45
- Pages
- 102437–102437
- Publication date
- 6 January 2026
- Language
- EN